Dr. Martin Steiner has been CEO of Synimmune GmbH since 2016 and an independent consultant for biotech and medtech companies. From 2005 to 2012 he was the CEO and co-founder of ImVisioN GmbH, a biotech company focusing on the development of immuno therapies and the treatment of allergies. In 1997, he founded EVAX Technologies, a biotech company focusing on the development of vaccines. He was the CEO of EVAX Technologies until 2004. Dr. Martin Steiner pursued a doctorate at the University of Vienna in Microbiology and Genetics and finished with an MBA at the University of Michigan.